Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now?-Reference-Cited by-同舟云学术

Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now?

Published:2013-07 Issue:3 Volume:27 Page:76-84
ISSN:0955-470X
Container-title:Transplantation Reviews
language:en
Short-container-title:Transplantation Reviews

Author:

Zuckermann Andreas,Wang Shoei-Shen,Epailly Eric,Barten Markus J.,Sigurdardottir Vilborg,Segovia Javier,Varnous Shaida,Turazza Fabio M.,Potena Luciano,Lehmkuhl Hans B.

Funder

Teva Pharmaceutical Industries

Roche

Novartis

Astellas Pharma US

Publisher

Elsevier BV

Subject

Transplantation

Reference82 articles.

1. Everolimus: efficacy and safety in cardiac transplantation;Schaffer;Expert Opin Drug Saf,2010

2. Clinical recommendations for the use of everolimus in heart transplantation;Manito;Transplant Rev (Orlando),2010

3. Eisen H, Kobashigawa J, Starling RC, et al. Everolimus versus mycophenolate mofetil in heart transplantation: a randomised, multicentre trial. Am J Transplant 2013. http://dx.doi.org/10.1111/ajt.12181. [Epub ahead of print].

4. Efficacy and safety of low-dose cyclosporine with everolimus and steroids in de novo heart transplant patients: a multicentre, randomized trial;Zuckermann;J Transplant.,2011

5. 2411 Study Investigators: everolimus with reduced cyclosporine versus MMF with standard cyclosporine in de novo heart transplant recipients;Lehmkuhl;Transplantation,2009

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial;The Journal of Heart and Lung Transplantation;2024-07

2. Effects of transplantation-related immunosuppression on co-existent neuroendocrine tumours;QJM: An International Journal of Medicine;2022-02-10

3. Risk factors for early development of cardiac allograft vasculopathy by intravascular ultrasound;Clinical Transplantation;2020-10-22

4. Immunosuppressive Drugs in Heart Transplantation;Frontiers in Cardiovascular Drug Discovery: Volume 4;2019-04-02

5. mTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in Transplantation;Transplantation;2019-04